The multiple roles of Fas ligand in the pathogenesis of infectious diseases

Clinical Microbiology and Infection

Volumn 9, Issue 8, 2003, Pages 766-779

  Dockrell, D H ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Apoptosis; Fas ligand; Infection; Lymphocytes

Indexed keywords

FAS ANTIGEN; FAS LIGAND; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; BACTERIAL INFECTION; CELL KILLING; CELL SURVIVAL; EFFECTOR CELL; HOMEOSTASIS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; LYMPHOCYTE DEPLETION; MYCOSIS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UPREGULATION; VIRUS INFECTION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0141739361     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00669.x     Document Type: Review

References (111)

1. Hetts SW. To die or not to die. An overview of apoptosis and its role in disease. JAMA 1998; 279: 300-7.
2. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature 2000; 407: 784-8.
3. Roy S, Nicholson DW. Cross-talk in cell death signaling. J Exp Med 2000; 192: F21-5.
4. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281: 1305-8.
5. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-12.
6. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6.
7. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998; 281: 1312-16.
8. Watanabe-Fukunaga R, Brannan CI, Itoh N et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 1992; 148: 1274-9.
9. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 1998; 282: 290-3.
10. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-78.
11. Kayagaki N, Kawasaki KN, Ohmoto ET et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182: 1777-83.
12. Kiener PA, Davis PM, Rankin BM et al. Human monocytic cells contain high levels of intracellular Fas ligand. Rapid release following cellular activation. J Immunol 1997; 159: 1594-8.
13. Krammer PH. CD95's deadly mission in the immune system. Nature 2000; 407: 789-95.
14. Siegel RM, Frederiksen JK, Zacharias DA et al. Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. Science 2000; 288: 2354-7.
15. Cremesti A, Paris F, Grassme H et al. Ceramide enables Fas to cap and kill. J Biol Chem 2001; 276: 23954-61.
16. Schneider P, Holler N, Bodmer JL et al. Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 1998; 187: 1205-13.
17. Ottonello L, Tortolina G, Amelotti M, Dallegri F. Soluble Fas ligand is chemotactic for human neutrophilic polymorphonuclear leukocytes. J Immunol 1999; 162: 3601-6.
18. Hohlbaum AM, Moe S, Marshak-Rothstein A. Opposing effects of transmembrane and soluble Fas ligand expression on inflammation and tumor cell survival. J Exp Med 2000; 191: 1209-20.
19. Rochat-Steiner V, Becker K, Micheau O, Schneider P, Burns K, Tschopp J. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH (2)-terminal kinase activation. J Exp Med 2000; 192: 1165-74.
20. Irmler M, Thome M, Hahne M et al. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190-5.
21. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
22. Villunger A, Huang DCS, Holler N, Tschopp J, Strasser A. Fas ligand-induced c-Jun kinase activation in lymphoid cells requires extensive receptor aggregation but is independent of DAXX, and Fas-mediated cell death does not involve DAXX, RIP or RAIDD. J Immunol 2000; 165: 1337-43.
23. Holler N, Zaru R, Micheau O et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nature Immunol 2000; 1: 489-95.
24. Zhang J, Gao JX, Salojin K et al. Regulation of Fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. J Exp Med 2000; 191: 1017-30.
25. Fisher GH, Rosenberg FJ, Straus SE et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81: 935-46.
26. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96: 2951-64.
27. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995; 181: 2029-36.
28. Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin K-M. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 1996; 88: 1741-6.
29. + T cells. Proc Natl Acad Sci USA 1996; 93: 11014-18.
30. Westendorp MO, Frank R, Ochsenbauer C et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995; 375: 497-500.
31. Li-Weber M, Laur O, Dern K, Krammer PH. T cell activation-induced and HIV Tat-enhanced CD95 (APO-1/Fas) ligand transcription involve NF-kappaB. Eur J Immunol 2000; 30: 661-70.
32. Yang Y, Dong B, Mittelstadt PR, Xiao H, Ashwell JD. HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. J Biol Chem 2002; 277: 19482-7.
33. Bartz SR, Emerman M. Human immunodeficiency vius type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 1999; 73: 1956-63.
34. Xu XN, Laffert B, Screaton GR et al. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 1999; 189: 1489-96.
35. + T cells by a Fas-independent mechanism. J Exp Med 1998; 187: 1113-22.
36. Finkel TH, Tudor-Williams G, Banda NK et al. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995; 1: 129-34.
37. Vlahakis SR, Algeciras-Schimnich A, Bou G et al. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J Clin Invest 2001; 107: 207-15.
38. + T cells. Proc Natl Acad Sci USA 1998; 95: 12556-61.
39. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC. HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 2001; 410: 834-8.
40. Jacotot E, Ravagnan L, Loeffler M et al. The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med 2000; 191: 33-45.
41. Kaplan D, Sieg S. Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease. J Virol 1998; 72: 6279-82.
42. Tateyama M, Oyaizu N, McCloskey TW, Than S, Pahwa S. CD4 T lymphocytes are primed to express Fas ligand by CD4 cross-linking and to contribute to CD8 T-cell apoptosis via Fas/FasL death signaling pathway. Blood 2000; 96: 195-202.
43. Mueller YM, De Rosa SC, Hutton JA et al. Increased CD95/Fas-induced apoptosis of HIV-specific CD8 (+) T cells. Immunity 2001; 15: 871-82.
44. Xu X-N, Screaton GR, Gotch FM et al. Evasion of cytotoxic T lymphocyte (CTL) responses by Nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med 1997; 186: 7-16.
45. Dockrell DH, Badley AD, Villacian JS et al. The expression of Fas ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest 1998; 101: 2394-405.
46. Cohen SS, Li C, Ding L et al. Pronounced acute immunosuppression in vivo mediated by HIV Tat challenge. Proc Natl Acad Sci USA 1999; 96: 10842-7.
47. + T cells apoptosis: a possible mechanism of bystander cell death in HIV infection. J Immunol 1997; 158: 2456-63.
48. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med 1997; 185: 55-64.
49. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4. Nature 1998; 395: 189-94.
50. Sieg S, Smith D, Yildirim Z, Kaplan D. Fas ligand deficiency in HIV disease. Proc Natl Acad Sci USA 1997; 94: 5860-5.
51. Shankar P, Xu Z, Lieberman J. Viral-specific cytotoxic T lymphocytes lyse human immunodeficiency virus-infected primary T lymphocytes by the granule exocytosis pathway. Blood 1999; 94: 3084-93.
52. + T cells from human immunodeficiency virus-infected persons. J Exp Med 1995; 182: 1759-67.
53. Gougeon ML, Lecoeur H, Boudet F et al. Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 1997; 158: 2964-76.
54. Badley AD, Dockrell DH, Algeciras A et al. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest 1998; 102: 79-87.
55. + T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 1999; 94: 1021-7.
56. + T cells in vitro and in vivo: association with Fas-mediated apoptosis and modulation by aurintricarboxylic acid. Immunology 1996; 87: 581-5.
57. + T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure role of changes in thymic output and T cell death. J Infect Dis 2001; 183: 1009-16.
58. Galle PR, Hofmann WJ, Walczak H et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-30.
59. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nature Med 1997; 3: 409-13.
60. Lee MO, Kang HJ, Cho H, Shin EC, Park JH, Kim SJ. Hepatitis B virus X protein induced expression of the Nur77 gene. Biochem Biophys Res Commun 2001; 288: 1162-8.
61. Nakamura K, Yuh K, Sugyo S, Shijo H, Kimura N, Okumura M. Apoptosis observed in peripheral T lymphocytes from patients with chronic hepatitis B. Gastroenterology 1996; 111: 156-64.
62. Milich DR, Chen MK, Hughes JL, Jones JE. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998; 160: 2013-21.
63. Hiramatsu N, Hayashi N, Katayama K. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-9.
64. Mita E, Hayashi N, Iio S et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem Biophys Res Commun 1994; 204: 468-74.
65. Ando K, Hiroishi K, Kaneko T et al. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 1997; 158: 5283-91.
66. Huber S, Shi C, Budd RC. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J Virol 2002; 76: 6487-94.
67. Snow AL, Chen LJ, Nepomuceno RR, Krams SM, Esquivel CO, Martinez OM. Resistance to Fas-mediated apoptosis in EBV-infected B cell lymphomas is due to defects in the proximal Fas signaling pathway. J Immunol 2001; 167: 5404-11.
68. Tanner JE, Alfieri C. Epstein-Barr virus induces Fas (CD95) in T cells and Fas ligand in B cells leading to T-cell apoptosis. Blood 1999; 94: 3439-47.
69. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity 2001; 15: 997-1009.
70. Zhang H-G, Fleck M, Kern ER et al. Antigen-presenting cells expressing Fas ligand down-modulate chronic inflammatory disease in Fas ligand-deficient mice. J Clin Invest 2000; 105: 813-21.
71. Larochelle B, Flamand L, Gourde P, Beauchamp D, Gosselin J. Epstein-Barr virus infects and induces apoptosis in human neutrophils. Blood 1998; 92: 291-9.
72. Colamussi ML, White MR, Crouch E, Hartshorn KL. Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 1999; 93: 2395-403.
73. Chiou S-H, Liu J-H, Hsu W-M et al. Up-regulation of Fas ligand expression by human cytomegalovirus immediate-early gene product 2: a novel mechanism in cytomegalovirus-induced apoptosis in human retina. J Immunol 2001; 167: 4098-103.
74. Cinatl J Jr, Blaheta R, Bittoova M et al. Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of Fas ligand independent of neutrophil apoptosis. J Immunol 2000; 165: 4405-13.
75. Kornfeld H, Mancino G, Colizzi V. The role of macrophage cell death in tuberculosis. Cell Death Differentiation 1999; 6: 71-8.
76. Keane J, Remold HG, Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 2000; 164: 2016-20.
77. Rojas M, Barrera LF, Puzo G, Garcia LF. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages. J Immunol 1997; 159: 1352-61.
78. Silva CL, Lowrie DB. Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis. Infect Immun 2000; 68: 3269-74.
79. Oddo M, Renno T, Attinger A, Bakker T, Robson MacDonald H, Meylan PRA. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 1998; 160: 5448-54.
80. 7) receptors. Immunity 1997; 7: 433-44.
81. + T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism. J Immunol 2001; 167: 2734-42.
82. Fratazzi C, Arbeit RD, Carini C et al. Macrophage apoptosis in mycobacterial infections. J Leukocyte Biol 1999; 66: 763-4.
83. Bermudez LE, Parker A, Petrofsky M. Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases. Clin Exp Immunol 1999; 116: 94-9.
84. Laochumroonvaropong P, Paul S, Elkon KB, Kaplan G. H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect Immun 1996; 64: 452-9.
85. Mustafa T, Phyu S, Nilsen R, Bjune G, Jonsson R. Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis. Inflammation 1999; 23: 507-21.
86. Kremer L, Estaquier J, Wolowczuk I, Beit F, Ameisen JC, Locht C. Ineffective cellular immune response associated with T-cell apoptosis in susceptible Mycobacterium bovis BCG-infected mice. Infect Immun 2000; 68: 4264-73.
87. Li B, Bassiri H, Rossman MD et al. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human γδ T cells: a mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis. J Immunol 1998; 161: 1558-67.
88. Hirsch CS, Toossi Z, Johnson JL et al. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis 2001; 183: 779-88.
89. Viera NT, Romero MJ, Montero MK, Rincon J, Mosquera JA. Streptococcal erythrogenic toxin B induces apoptosis and proliferation in human leukocytes. Kidney Int 2001; 59: 950-8.
90. Brunner T, Mogil RJ, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441-4.
91. McLeod JD, Walker LSK, Patel YI, Boulougouris G, Sansom DM. Activation of human T cells with superantigen (staphylococcal enterotoxin B) and CD28 confers resistance to apoptosis via CD95. J Immunol 1998; 160: 2072-9.
92. Mountz JD, Baker TJ, Borcherding DR, Bluethmann H, Zhou T, Edwards CK 3rd. Increased susceptibility of Fas mutant MRL-lpr/lpr mice to staphylococcal enterotoxin B-induced septic shock. J Immunol 1995; 155: 4829-37.
93. Hohlbaum AM, Gregory MS, Ju ST, Marshak-Rothstein A. Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol 2001; 167: 6217-24.
94. Nwakoby IE, Reddy K, Patel P et al. Fas-mediated apoptosis of neutrophils in sera of patients with infection. Infect Immun 2001; 69: 3343-9.
95. Baran J, Weglarczyk K, Mysiak M et al. Fas (CD95)-Fas ligand interactions are responsible for monocyte apoptosis occurring as a result of phagocytosis and killing of Staphylococcus aureus. Infect Immun 2001; 69: 1287-97.
96. Dockrell DH, Lee M, Lynch DH, Read RC. Immune-mediated phagocytosis and killing of Streptococcus pneumoniae are associated with direct and bystander macrophage apoptosis. J Infect Dis 2001; 184: 713-22.
97. Brown SB, Savill J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J Immunol 1999; 162: 480-5.
98. Matute-Bello G, Frevert CW, Liles WC et al. Fas/Fas ligand system mediates epithelial injury, but not pulmonary host defenses, in response to inhaled bacteria. Infect Immun 2001; 69: 5768-76.
99. + synovial T cells by borrelia-reactive Fas-ligand (high) gamma delta T cells in Lyme arthritis. J Exp Med 1996; 184: 2109-17.
100. Raqib R, Ekberg C, Sharkar P et al. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-1. Infect Immun 2002; 70: 3199-207.
101. Grassme H, Kirschnek S, Riethmueller J et al. CD95/CD95 ligand interactions on epithelial cells in host defense to Pseudomonas aeruginosa. Science 2000; 290: 527-30.
102. Kitamura Y, Hashimoto S, Mizuta N et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am J Respir Crit Care Med 2001; 163: 762-9.
103. Rudi J, Kuck D, Strand S. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J Clin Invest 1998; 102: 1506-14.
104. + T lymphocytes from infected hosts. J Immunol 1998; 160: 1313-19.
105. Lopes MF, Nunes MP, Henriques-Pons A et al. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response. Eur J Immunol 1999; 29: 81-9.
106. Zuniga E, Motran CC, Montes CL, Yagita H, Gruppi A. Trypanosoma cruzi infection selectively renders parasite-specific IgG+ B lymphocytes susceptible to Fas/Fas ligand-mediated fratricide. J Immunol 2002; 168: 3965-73.
107. Conceicao-Silva F, Hahne M, Schroter M, Louis J, Tschopp J. The resolution of lesions induced by Leishmania major in mice requires a functional Fas (APO-1, CD95) pathway of cytotoxicity. Eur J Immunol 1998; 28: 237-45.
108. Lundy SK, Lerman SP, Boros DL. Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL (+) T and B cells during murine Schistosoma mansoni infection. Infect Immun 2001; 69: 271-80.
109. Chen X-M, Gores GJ, Paya CV, LaRusso NF. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am J Physiol 1999; 277(3 Part 1): G599-608.
110. Kuroda A, Uchikawa R, Matsuda S, Yamada M, Tegoshi T, Arizono N. Up-regulation of Fas (CD95) and induction of apoptosis in intestinal epithelial cells by nematode-derived molecules. Infect Immun 2002; 70: 4002-8.
111. 3 in T lymphocytes. J Immunol 2002; 168: 1154-66.